Looking to sell Nalu Medical stock or options?
Nalu Medical develops neuro-stimulation devices aimed at alleviating chronic pain. The company's innovative battery-free, micro-implantable pulse generators focus on neuromodulation, offering diverse therapy options for spinal cord and peripheral nerve stimulation. This technology enables patients with clinical conditions to access appropriate treatments and effectively manage chronic pain.
Endeavour Vision, Pura Vida Investments, Boston Scientific, Advent Life Sciences, Boston Scientific Ventures, Novo Holdings, Gilde Healthcare, B Capital Group, Aperture Venture Partners, Runway Growth Capital, Longitude Capital, Decheng Capital, MVM Partners.
Nalu Medical is currently a private company. This means that the company is not listed on any public exchange and so there is no public market for its stock. However, there may still be ways to monetize Nalu Medical stock. Depending on Nalu Medical’s policies, you may be able to: (1) find a private buyer in the secondary market to purchase your stock, (2) borrow against your stock, or (3) exchange Nalu Medical stock into the Collective Exchange Fund for a limited partnership interest and then borrow non-recourse against your interest to generate immediate cash. This last alternative can be much quicker and net you more after-tax cash than your other options. An exchange into our fund also reduces your risk by diversifying your holdings out of an over-concentrated position.
Collective Liquidity can provide liquidity to shareholders of Nalu Medical stock in two ways. First, Nalu Medical employees can exchange shares into the Collective Exchange Fund and then borrow non-recourse to generate immediate cash. This can net you more after-tax cash than a stock sale. It also reduces your risk by diversifying your holdings out of an over-concentrated position. In some cases, Collective may also be able to purchase your Nalu Medical stock. Note that all transactions in Nalu Medical shares are subject to the company’s policies regarding secondary transactions. Schedule a call with a Collective Liquidity representative to learn more about your private market liquidity alternatives.
Nalu Medical stock is not listed on any public exchange and so there is no public market for its shares. Therefore, there is no single, centralized price for Nalu Medical stock. Typically, shares of private companies like Nalu Medical are set with buyers in one off negotiations. Collective Liquidity, however, uses a proprietary algorithm to determine its bids so we almost always have an immediately actionable price for you.
On Dec 2023, Nalu Medical is reported to have closed an equity financing in which the investors valued the company at $383M. This valuation is typically calculated by multiplying the per share price of the preferred stock sold in the financing by the number of Nalu Medical shares outstanding assuming the conversion of all stock options, warrants, etc.
Tickers are used to identify company’s shares on public markets like the NYSE or Nasdaq. Because Nalu Medical is not currently publicly traded, it does not have a ticker symbol.
Nalu Medical has not yet conducted an initial public offering (“IPO”) and so remains a private company. Though Nalu Medical is a well-known, successful company, there can be no assurance that it will ever go public or be sold. Because of the risk this imposes on Nalu Medical shareholders, many investors elect to gain liquidity for at least some of their shares before the IPO. Schedule a call with a Collective Liquidity representative to discuss your private market liquidity alternatives.